Trial
NCT03446599
Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
—
Condition
Vasoplegia
Intervention
Hydroxocobalamin
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-02